Company Overview
Laxmi Dental Limited (BSE: 544339, NSE: LAXMIDENTL) reported strong financial performance for FY 2025-26 with consolidated revenue growth of 22% to INR 2,778.58 million and profit of INR 289.17 million. The company convened its 22nd AGM on September 25, 2026, submitting comprehensive financial statements and operational updates to exchanges.
Financial Performance
Revenue & Profitability:
Standalone revenue grew 16.21% to INR 2,165.82 million while PAT stood at INR 193.37 million. Consolidated performance showed revenue of INR 2,864.04 million with PAT of INR 289.17 million. Profitability was impacted by USA tariffs, geopolitical situation, increased ESOP expenses (INR 52.61 million), and exceptional charge of INR 57.79 million from new labor code implementation.
Business Segment Performance:
Domestic laboratory business grew 10.20% while international laboratory business expanded 29.15%. Scanner business achieved 85.91% sales growth with 1,009 units sold. Digital penetration reached 75.53% in domestic and 75.22% in international laboratory operations. The company maintained leadership as India's largest dental exporter with INR 965.39 million in export value.
Strategic Developments
IPO Proceeds Utilization:
Of the total INR 1,281.70 million IPO proceeds, 62.47% (INR 800.67 million) has been utilized as per original objects. The company seeks shareholder approval to vary unutilized INR 481.03 million for land acquisition (INR 268.96 million) and construction of new manufacturing facility (INR 212.07 million) to support digital dentistry solutions expansion.
Investments & Expansion:
Strategic investments totaling INR 515.86 million were made in subsidiaries and joint ventures, including INR 409.15 million in Bizdent Devices, INR 85.70 million in Laxmi Dental Lab USA, and INR 20.01 million in AI joint venture IDBG AI Dent Global. The Board approved merger of Bizdent Devices with Laxmi Dental, pending regulatory approvals.
Corporate Actions & Governance
ESOP & Capital Structure:
ESOP allotments of 67,271 shares were made during the year. No dividend was recommended for FY26 to conserve resources. Market capitalization stood at INR 9,060.51 million with 100% shares in dematerialized form. Promoter holding remained at 32.99% with OrbiMed Asia II holding 22.41%.
Regulatory Compliance:
The company faced fines for delayed compliance disclosures but maintained strong corporate governance with 8 Board meetings. CSR expenditure of INR 14.35 lakh was made towards PM National Relief Fund. All regulatory filings were completed as per SEBI LODR requirements.
Operational Metrics
With 6 manufacturing facilities across 1,47,000 sq. ft., the company serves over 22,000 clinics across 95+ countries. Employee strength stood at 2,513 as of March 31, 2026. New product launches included Teen Aligners and Personalised Early Orthodontic Treatment, alongside AI-enabled iScope 360 platform.
Forward Outlook
The global dental services market is projected to grow from USD 579.7 billion in 2025 to USD 776 billion by 2030. Laxmi Dental is positioned to capitalize on rising digital adoption and expanding Indian dental devices market through strategic investments and capacity expansion initiatives.